$5.09 Billion is the total value of Orbimed Advisors's 125 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 37.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SVA | SINOVAC BIOTECH LTD | $340,000,000 | 0.0% | 2,718,735 | 0.0% | 6.67% | +2.6% | |
| New | ENLIVEN THERAPEUTICS INC | $197,017,065 | – | 8,996,213 | +100.0% | 3.87% | – | |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $189,613,700 | +5.1% | 3,790,000 | -2.8% | 3.72% | +7.9% |
| HUM | HUMANA INC | $169,279,902 | -5.2% | 348,700 | 0.0% | 3.32% | -2.8% | |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $162,185,400 | -12.8% | 2,340,000 | -9.5% | 3.18% | -10.5% |
| ISRG | INTUITIVE SURGICAL INC | $158,519,135 | -3.7% | 620,500 | 0.0% | 3.11% | -1.2% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $157,063,020 | -6.0% | 1,615,210 | 0.0% | 3.08% | -3.6% | |
| THESEUS PHARMACEUTICALS INC | $153,034,972 | +78.3% | 17,233,668 | 0.0% | 3.00% | +82.9% | ||
| BIIB | Buy | BIOGEN INC | $140,405,150 | +96.4% | 505,000 | +95.6% | 2.76% | +101.5% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $130,434,840 | -35.3% | 276,000 | -27.5% | 2.56% | -33.6% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $119,236,733 | -5.4% | 865,100 | -11.0% | 2.34% | -2.9% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $115,801,686 | -15.2% | 4,498,900 | -14.3% | 2.27% | -13.0% |
| SYK | Sell | STRYKER CORPORATION | $104,938,772 | -10.8% | 367,600 | -23.6% | 2.06% | -8.4% |
| EWTX | EDGEWISE THERAPEUTICS INC | $97,163,064 | -25.4% | 14,567,176 | 0.0% | 1.91% | -23.4% | |
| EVH | Buy | EVOLENT HEALTH INCcl a | $93,963,258 | +18.5% | 2,895,632 | +2.5% | 1.84% | +21.6% |
| TERN | TERNS PHARMACEUTICALS INC | $90,210,558 | +16.3% | 7,619,135 | 0.0% | 1.77% | +19.3% | |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $85,554,675 | -28.4% | 4,260,691 | -6.8% | 1.68% | -26.5% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $85,187,486 | -23.5% | 147,800 | -26.9% | 1.67% | -21.5% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $75,929,630 | +0.8% | 2,124,500 | +6.6% | 1.49% | +3.5% |
| CMPX | COMPASS THERAPEUTICS INC | $73,126,520 | -35.0% | 22,362,850 | 0.0% | 1.44% | -33.3% | |
| THC | TENET HEALTHCARE CORP | $72,510,226 | +21.8% | 1,220,300 | 0.0% | 1.42% | +24.9% | |
| KROS | KEROS THERAPEUTICS INC | $71,711,106 | -11.1% | 1,679,417 | 0.0% | 1.41% | -8.7% | |
| LLY | New | LILLY ELI & CO | $63,876,120 | – | 186,000 | +100.0% | 1.25% | – |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $63,449,784 | +8.5% | 3,950,796 | +23.6% | 1.25% | +11.3% |
| BAX | New | BAXTER INTL INC | $63,354,720 | – | 1,562,000 | +100.0% | 1.24% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $60,036,792 | – | 910,200 | +100.0% | 1.18% | – |
| SIBN | Sell | SI-BONE INC | $57,425,660 | +25.4% | 2,919,454 | -13.3% | 1.13% | +28.7% |
| PRLD | PRELUDE THERAPEUTICS INC | $57,226,239 | -5.6% | 10,039,691 | 0.0% | 1.12% | -3.2% | |
| SBTX | ARS PHARMACEUTICALS INC | $56,903,174 | -23.7% | 8,740,887 | 0.0% | 1.12% | -21.7% | |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $55,956,432 | -28.6% | 177,600 | -34.6% | 1.10% | -26.8% |
| NTRA | Sell | NATERA INC | $54,053,217 | -30.9% | 973,581 | -50.0% | 1.06% | -29.1% |
| Sell | PRELUDE THERAPEUTICS INCnonvoting | $53,820,418 | +4.5% | 11,895,652 | -2.1% | 1.06% | +7.3% | |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $52,119,900 | -18.8% | 630,000 | -26.8% | 1.02% | -16.7% |
| SCPH | SCPHARMACEUTICALS INC | $50,424,919 | +26.5% | 5,559,528 | 0.0% | 0.99% | +29.8% | |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $49,496,580 | -39.7% | 489,000 | -28.9% | 0.97% | -38.1% |
| Buy | DISC MEDICINE INC | $48,093,608 | +11.9% | 2,269,637 | +5.0% | 0.94% | +14.8% | |
| KDNY | CHINOOK THERAPEUTICS INC | $46,978,295 | -11.6% | 2,029,300 | 0.0% | 0.92% | -9.3% | |
| XTNT | XTANT MED HLDGS INC | $46,610,552 | -3.4% | 73,114,592 | 0.0% | 0.92% | -0.9% | |
| VECT | Sell | VECTIVBIO HLDG AG | $43,882,334 | -27.7% | 5,156,561 | -26.4% | 0.86% | -25.8% |
| ACET | ADICET BIO INC | $42,895,526 | -35.6% | 7,447,140 | 0.0% | 0.84% | -33.9% | |
| QURE | Buy | UNIQURE NV | $41,578,124 | +5.0% | 2,064,455 | +18.1% | 0.82% | +7.7% |
| XENE | XENON PHARMACEUTICALS INC | $41,126,289 | -9.2% | 1,149,100 | 0.0% | 0.81% | -6.9% | |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $39,229,307 | +48.9% | 1,744,300 | +39.2% | 0.77% | +52.8% |
| MRSN | MERSANA THERAPEUTICS INC | $37,037,006 | -29.9% | 9,011,437 | 0.0% | 0.73% | -28.0% | |
| BLU | Buy | BELLUS HEALTH INC NEW | $36,755,893 | -4.9% | 5,108,900 | +8.5% | 0.72% | -2.4% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $36,150,576 | -29.2% | 1,711,675 | -14.7% | 0.71% | -27.3% |
| JANX | JANUX THERAPEUTICS INC | $34,320,271 | -8.1% | 2,836,386 | 0.0% | 0.67% | -5.7% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $33,969,507 | -41.6% | 913,650 | -28.8% | 0.67% | -40.1% |
| PGNY | Buy | PROGYNY INC | $33,337,733 | +3.4% | 1,037,912 | +0.3% | 0.65% | +6.0% |
| RPTX | REPARE THERAPEUTICS INC | $32,693,282 | -33.1% | 3,322,488 | 0.0% | 0.64% | -31.3% | |
| TELA | TELA BIO INC | $32,213,047 | -7.5% | 3,027,542 | 0.0% | 0.63% | -5.1% | |
| KNTE | Buy | KINNATE BIOPHARMA INC | $32,147,681 | +30.3% | 5,143,629 | +27.2% | 0.63% | +33.7% |
| ALPN | ALPINE IMMUNE SCIENCES INC | $31,509,890 | +5.0% | 4,081,592 | 0.0% | 0.62% | +7.8% | |
| ABCL | ABCELLERA BIOLOGICS INC | $31,522,991 | -25.6% | 4,180,768 | 0.0% | 0.62% | -23.6% | |
| PMVP | PMV PHARMACEUTICALS INC | $31,305,877 | -45.2% | 6,563,077 | 0.0% | 0.62% | -43.7% | |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $28,762,568 | +124.2% | 4,707,458 | +134.5% | 0.56% | +130.6% |
| PCVX | Sell | VAXCYTE INC | $27,339,374 | -55.6% | 729,439 | -43.2% | 0.54% | -54.4% |
| New | R1 RCM INC | $26,250,000 | – | 1,750,000 | +100.0% | 0.52% | – | |
| Buy | 2SEVENTY BIO INC | $24,394,606 | +150.0% | 2,391,628 | +129.7% | 0.48% | +156.1% | |
| New | AMYLYX PHARMACEUTICALS INC | $23,868,090 | – | 813,500 | +100.0% | 0.47% | – | |
| THIRD HARMONIC BIO INC | $23,809,773 | -4.2% | 5,779,071 | 0.0% | 0.47% | -1.7% | ||
| RAPT | RAPT THERAPEUTICS INC | $22,957,135 | -7.3% | 1,251,070 | 0.0% | 0.45% | -4.9% | |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $21,828,000 | +12.2% | 200,000 | +17.0% | 0.43% | +15.3% |
| ARQT | Sell | ARCUTIS BIOTHERAPEUTICS INC | $21,059,269 | -42.2% | 1,914,479 | -22.2% | 0.41% | -40.7% |
| XBI | Buy | SPDR SER TRs&p biotech | $20,881,540 | +229.3% | 274,000 | +258.6% | 0.41% | +238.8% |
| RXSIGHT INC | $20,063,254 | +31.6% | 1,202,833 | 0.0% | 0.39% | +34.9% | ||
| REGN | New | REGENERON PHARMACEUTICALS | $19,720,080 | – | 24,000 | +100.0% | 0.39% | – |
| Sell | VENTYX BIOSCIENCES INC | $19,597,500 | -35.4% | 585,000 | -36.8% | 0.38% | -33.6% | |
| NPCE | NEUROPACE INC | $18,616,984 | +211.4% | 4,012,281 | 0.0% | 0.36% | +220.2% | |
| AMGN | New | AMGEN INC | $18,542,225 | – | 76,700 | +100.0% | 0.36% | – |
| GRCL | Buy | GRACELL BIOTECHNOLOGIES INCsponsored ads | $17,665,860 | -2.6% | 9,497,774 | +20.5% | 0.35% | 0.0% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $17,099,190 | -47.0% | 5,463,000 | +19.2% | 0.34% | -45.5% |
| ARGX | Buy | ARGENX SEsponsored adr | $16,579,810 | +170.2% | 44,500 | +174.7% | 0.32% | +177.8% |
| New | APOLLOMICS INC | $16,033,976 | – | 662,561 | +100.0% | 0.32% | – | |
| AVTE | Sell | AEROVATE THERAPEUTICS INC | $15,267,278 | -31.4% | 756,930 | -0.3% | 0.30% | -29.6% |
| DBTX | DECIBEL THERAPEUTICS INC | $14,934,480 | +47.3% | 4,945,192 | 0.0% | 0.29% | +51.0% | |
| BAX | New | BAXTER INTL INCcall | $14,196,000 | – | 350,000 | +100.0% | 0.28% | – |
| GHRS | Buy | GH RESEARCH PLCordinary shares | $13,255,530 | -15.9% | 1,659,015 | +2.3% | 0.26% | -13.9% |
| ALXO | ALX ONCOLOGY HLDGS INC | $12,976,920 | -59.9% | 2,871,000 | 0.0% | 0.26% | -58.8% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $12,986,390 | +106.1% | 1,171,000 | +126.9% | 0.26% | +110.7% |
| Sell | BRIDGEBIO PHARMA INCnote 2.250% 2/0 | $12,853,200 | +2.0% | 20,000,000 | -33.3% | 0.25% | +4.6% | |
| FUSN | Sell | FUSION PHARMACEUTICALS INC | $11,772,843 | +15.9% | 3,122,770 | -3.2% | 0.23% | +19.1% |
| IKNA | Buy | IKENA ONCOLOGY INC | $10,992,273 | +40.8% | 3,186,166 | +8.6% | 0.22% | +45.0% |
| GDRX | Buy | GOODRX HLDGS INC | $10,625,000 | +488.3% | 1,700,000 | +338.6% | 0.21% | +497.1% |
| VERA | New | VERA THERAPEUTICS INCcl a | $10,572,224 | – | 1,362,400 | +100.0% | 0.21% | – |
| SRPT | New | SAREPTA THERAPEUTICS INCcall | $10,337,250 | – | 75,000 | +100.0% | 0.20% | – |
| BCAB | Buy | BIOATLA INC | $10,347,480 | +277.4% | 3,861,000 | +1061.7% | 0.20% | +290.4% |
| Sell | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $9,468,750 | +19.1% | 12,500,000 | -37.5% | 0.19% | +22.4% | |
| PASG | PASSAGE BIO INC | $8,554,175 | -30.6% | 8,931,999 | 0.0% | 0.17% | -28.8% | |
| GLTO | GALECTO INC | $8,140,965 | +73.0% | 4,090,937 | 0.0% | 0.16% | +77.8% | |
| ORIC | Sell | ORIC PHARMACEUTICALS INC | $7,834,468 | -17.3% | 1,374,468 | -14.5% | 0.15% | -14.9% |
| XBI | New | SPDR SER TRcall | $7,621,000 | – | 100,000 | +100.0% | 0.15% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $6,923,000 | – | 301,000 | +100.0% | 0.14% | – |
| VSTM | VERASTEM INC | $6,852,144 | +3.2% | 16,503,237 | 0.0% | 0.14% | +6.3% | |
| New | YS BIOPHARMA CO LTDordinary shares | $6,877,542 | – | 4,298,464 | +100.0% | 0.14% | – | |
| IMTX | New | IMMATICS N.V | $6,536,011 | – | 947,248 | +100.0% | 0.13% | – |
| INVIVYD INC | $6,324,480 | -20.0% | 5,270,400 | 0.0% | 0.12% | -17.9% | ||
| CRVS | CORVUS PHARMACEUTICALS INC | $6,318,725 | +7.1% | 6,943,654 | 0.0% | 0.12% | +9.7% | |
| CGEM | Sell | CULLINAN ONCOLOGY INC | $6,193,109 | -7.9% | 605,387 | -5.0% | 0.12% | -5.4% |
| NTLA | New | INTELLIA THERAPEUTICS INC | $6,135,648 | – | 164,627 | +100.0% | 0.12% | – |
| MRTX | New | MIRATI THERAPEUTICS INCcall | $5,577,000 | – | 150,000 | +100.0% | 0.11% | – |
| MREO | Sell | MEREO BIOPHARMA GROUP PLCspon ads | $5,476,984 | -31.1% | 7,747,891 | -26.9% | 0.11% | -28.9% |
| HZNP | New | HORIZON THERAPEUTICS PUB Lput | $5,457,000 | – | 50,000 | +100.0% | 0.11% | – |
| XFOR | X4 PHARMACEUTICALS INC | $5,061,422 | -12.4% | 5,817,726 | 0.0% | 0.10% | -10.8% | |
| VIGIL NEUROSCIENCE INC | $4,394,643 | -21.7% | 448,891 | 0.0% | 0.09% | -19.6% | ||
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $4,120,000 | -48.2% | 515,000 | -41.4% | 0.08% | -46.7% |
| NXTC | NEXTCURE INC | $4,012,299 | +5.0% | 2,711,013 | 0.0% | 0.08% | +8.2% | |
| SYBX | SYNLOGIC INC | $3,810,957 | -16.8% | 6,029,995 | 0.0% | 0.08% | -14.8% | |
| CMMB | Sell | CHEMOMAB THERAPEUTICS LTDsponsored ads | $3,563,626 | -56.8% | 2,241,274 | -13.1% | 0.07% | -55.7% |
| EPIX | Buy | ESSA PHARMA INC | $3,559,061 | +286.6% | 1,198,337 | +228.0% | 0.07% | +288.9% |
| TARA | Sell | PROTARA THERAPEUTICS INC | $2,483,837 | +11.6% | 793,558 | -4.5% | 0.05% | +14.0% |
| BOLT | Buy | BOLT BIOTHERAPEUTICS INC | $2,141,990 | +113.7% | 1,541,000 | +99.9% | 0.04% | +121.1% |
| AFIB | ACUTUS MED INC | $1,996,883 | -34.4% | 2,648,386 | 0.0% | 0.04% | -32.8% | |
| RVNC | New | REVANCE THERAPEUTICS INC | $1,610,500 | – | 50,000 | +100.0% | 0.03% | – |
| HRTX | New | HERON THERAPEUTICS INC | $1,212,077 | – | 802,700 | +100.0% | 0.02% | – |
| PHGE | Buy | BIOMX INC | $964,254 | +83.6% | 3,161,489 | +12.4% | 0.02% | +90.0% |
| MRSN | New | MERSANA THERAPEUTICS INCcall | $865,977 | – | 210,700 | +100.0% | 0.02% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $726,840 | – | 1,034,059 | +100.0% | 0.01% | – |
| OMIC | SINGULAR GENOMICS SYSTEMS IN | $654,243 | -39.8% | 540,697 | 0.0% | 0.01% | -38.1% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $521,194 | -35.5% | 1,797,221 | 0.0% | 0.01% | -33.3% | |
| HARP | Sell | HARPOON THERAPEUTICS INC | $462,310 | -58.0% | 621,218 | -59.0% | 0.01% | -57.1% |
| NKTR | New | NEKTAR THERAPEUTICScall | $383,081 | – | 545,000 | +100.0% | 0.01% | – |
| ALT | New | ALTIMMUNE INCcall | $422,000 | – | 100,000 | +100.0% | 0.01% | – |
| ALT | New | ALTIMMUNE INC | $213,532 | – | 50,600 | +100.0% | 0.00% | – |
| GLUE | Exit | MONTE ROSA THERAPEUTICS INC | $0 | – | -27,369 | -100.0% | -0.00% | – |
| MACK | Exit | MERRIMACK PHARMACEUTICALS IN | $0 | – | -73,600 | -100.0% | -0.02% | – |
| Exit | PYXIS ONCOLOGY INC | $0 | – | -848,252 | -100.0% | -0.02% | – | |
| CLXPF | Exit | CYBIN INC | $0 | – | -5,386,299 | -100.0% | -0.03% | – |
| EYPT | Exit | EYEPOINT PHARMACEUTICALS INC | $0 | – | -487,642 | -100.0% | -0.03% | – |
| GRAY | Exit | GRAYBUG VISION INC | $0 | – | -4,163,347 | -100.0% | -0.04% | – |
| APLT | Exit | APPLIED THERAPEUTICS INC | $0 | – | -3,050,921 | -100.0% | -0.04% | – |
| AMRX | Exit | AMNEAL PHARMACEUTICALS INC | $0 | – | -1,583,490 | -100.0% | -0.06% | – |
| SNY | Exit | SANOFIcall | $0 | – | -100,000 | -100.0% | -0.09% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -36,300 | -100.0% | -0.10% | – |
| MRNA | Exit | MODERNA INC | $0 | – | -82,550 | -100.0% | -0.28% | – |
| IMRA | Exit | IMARA INC | $0 | – | -4,386,568 | -100.0% | -0.34% | – |
| Exit | CINCOR PHARMA INC | $0 | – | -1,906,000 | -100.0% | -0.45% | – | |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -2,758,434 | -100.0% | -0.83% | – |
| ETNB | Exit | 89BIO INC | $0 | – | -3,658,869 | -100.0% | -0.89% | – |
| PFE | Exit | PFIZER INC | $0 | – | -1,393,600 | -100.0% | -1.37% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -913,812 | -100.0% | -2.25% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 40 | Q1 2023 | 5.0% |
| VERTEX PHARMACEUTICALS INC | 40 | Q1 2023 | 3.7% |
| THERMO FISHER SCIENTIFIC INC | 40 | Q1 2023 | 3.2% |
| BRISTOL-MYERS SQUIBB CO | 39 | Q1 2023 | 5.2% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q1 2023 | 2.7% |
| SINOVAC BIOTECH LTD | 39 | Q1 2023 | 6.7% |
| BOSTON SCIENTIFIC CORP | 38 | Q1 2023 | 5.6% |
| AMGEN INC | 38 | Q1 2023 | 5.5% |
| INTUITIVE SURGICAL INC | 38 | Q1 2023 | 3.2% |
| GILEAD SCIENCES INC | 37 | Q2 2022 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Gracell Biotechnologies Inc. | March 31, 2023 | 7,583,576 | 11.2% |
| Terns Pharmaceuticals, Inc. | March 29, 2023 | 7,619,135 | 13.4% |
| 89bio, Inc.Sold out | March 24, 2023 | 0 | 0.0% |
| CalciMedica, Inc. | March 24, 2023 | 297,380 | 5.4% |
| Theseus Pharmaceuticals, Inc. | March 14, 2023 | 17,233,668 | 39.6% |
| Enliven Therapeutics, Inc. | February 28, 2023 | 8,949,339 | 21.8% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 1,797,221 | 2.9% |
| ALX ONCOLOGY HOLDINGS INC | February 14, 2023 | 2,266,000 | 5.6% |
| Applied Therapeutics Inc. | February 14, 2023 | 7,300,921 | 10.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2023 | 0 | 0.0% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-24 |
| SC 13D/A | 2023-05-24 |
| SC 13D | 2023-05-24 |
| 4 | 2023-05-19 |
| SC 13D/A | 2023-05-17 |
| SC 13D/A | 2023-05-16 |
| SC 13D/A | 2023-05-16 |
| 13F-HR | 2023-05-15 |
| 4 | 2023-05-15 |
| 144 | 2023-05-11 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.